pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
hypericin sodium
Cutaneous T-Cell Lymphoma
$SNGX
SOLIGENIX, INC.
0
catalysts
Phase 2
iCIP
LiPlacis (cisplatin)
Metastatic Breast Cancer
Chosa Oncology AB
0
catalysts
Preclinical
iDose Next Generation
Glaucoma
$GKOS
GLAUKOS Corp
0
catalysts
Phase 2
← prev
page 218 of 271
next →
131
Pain
89
Neurology
1
iLution travoprost
travoprost
Ocular Hypertension
Prostaglandin F2-alpha receptor
$GKOS
GLAUKOS Corp
0
catalysts
Preclinical
iTOL-102
Type 1 Diabetes (Juvenile Diabetes)
iTolerance Inc
0
catalysts
Preclinical
iVIEW-1701
Ocular Inflammation
iView Therapeutics Inc
0
catalysts
Preclinical
iXB-322
Coronavirus Disease 2019 (COVID-19)
iX Biopharma Ltd
0
catalysts
Phase 2
iadademstat
iadademstat [INN]
Small-Cell Lung Cancer
Oryzon Genomics SA
0
catalysts
Phase 3
ianalumab
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Tumor necrosis factor receptor superfamily member 13C
$NVS
NOVARTIS AG
0
catalysts
Marketed
ibalizumab
Trogarzo (ibalizumab-uiyk)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Theratechnologies Inc
0
catalysts
Phase 2
ibcasertib
ibcasertib [INN]
Breast Cancer
Shenzhen Chipscreen Biosciences Co Ltd
0
catalysts
Phase 2
ibezapolstat
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
$ACXP
Acurx Pharmaceuticals, Inc.
0
catalysts
Phase 3
ibramvibart
ibramvibart [INN]
Coronavirus Disease 2019 (COVID-19)
$IVVD
Invivyd, Inc.
0
catalysts
Phase 3
ibrilatazar
ibrilatazar [INN]
Metastatic Pancreatic Cancer
Ability Pharmaceuticals SL
0
catalysts
Marketed
ibritumomab tiuxetan
Zevalin (ibritumomab tiuxetan)
B-Cell Non-Hodgkin Lymphoma
Acrotech Biopharma Inc
0
catalysts
Marketed
ibrutinib
Imbruvica (ibrutinib)
Follicular Lymphoma
Tyrosine-protein kinase BTK
$ABBV
AbbVie Inc.
0
catalysts
Phase 3
ibudilast
ibudilast [INN]
Amyotrophic Lateral Sclerosis
$MNOV
MEDICINOVA INC
0
catalysts
Marketed
ibuprofen lysine
Neoprofen (ibuprofen lysine)
Patent Ductus Arteriosus
Recordati Rare Diseases Inc
0
catalysts
Phase 3
ibutamoren mesylate
Oratrope (ibutamoren mesylate)
Growth Hormone Deficiency
Growth hormone secretagogue receptor type 1
Lumos Pharma Inc
0
catalysts
Marketed
ibutilide fumarate
Ibutilide Fumarate (ibutilide fumarate)
Atrial Fibrillation
American Regent Inc
0
catalysts
Phase 3
ibuzatrelvir
Coronavirus Disease 2019 (COVID-19)
$PFE
PFIZER INC
0
catalysts
Marketed
icatibant acetate
Firazyr (icatibant acetate)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Takeda Pharmaceuticals USA Inc
0
catalysts
Marketed
icosapent ethyl
Alfa (icosapent ethyl)
Familial Adenomatous Polyposis
KD Pharma Group SA
0
catalysts
Phase 2
icovamenib
Type 2 Diabetes
$BMEA
Biomea Fusion, Inc.
0
catalysts
Marketed
idarucizumab
Praxbind (idarucizumab)
Bleeding And Clotting Disorders
Boehringer Ingelheim Corp
0
catalysts
Marketed
idecabtagene vicleucel
Abecma (idecabtagene vicleucel)
Refractory Multiple Myeloma
Celgene Corp
0
catalysts
Phase 2
idroxioleic acid
Malignant Glioma
Laminar Pharmaceuticals SA
0
catalysts
Marketed
idursulfase
Elaprase (idursulfase)
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Shire Human Genetic Therapies Inc
0
catalysts
Phase 2
ifenprodil
ifenprodil [INN]
Chronic Cough
Seyltx Inc
0
catalysts
Phase 2
ifetroban
Dyscorban (ifetroban)
Duchenne Muscular Dystrophy
$CPIX
CUMBERLAND PHARMACEUTICALS INC
0
catalysts
